Skip to main content
. 2022 Oct;14(10):4055–4072. doi: 10.21037/jtd-22-1185

Figure 6.

Figure 6

Correlations between the m6A-related lncRNA risk-score model and the clinicopathological characteristics. (A) The heatmap of m6A-related lncRNA expression and the clinicopathological characteristics. Patients in cluster B (B), with a high immune score (C) and with stage III–IV disease (D) had a higher risk score. Patients with a high-risk score had increased expressions of PD-L1 (E), PD-L2 (F) and CTLA4 (G). *, P<0.05; **, P<0.01, ***, P<0.001. Risk scores were positively related to M2 macrophages (H), neutrophils (I), active memory CD4 T cells (J), resting memory CD4 T cells (K) and γδ T cells (L). Naïve B cells (M), active natural killer cells (N), and follicular helper T cells (O) were negatively related to risk scores. N, node; M, metastasis; T, tumor; m6A, N6-methylandenosine; lncRNA, long non-coding RNA; PD-L1, programmed death-ligand 1; PD-L2, programmed death-ligand 2; CTLA4, cytotoxic T-lymphocyte-associated protein 4.